|
Volumn 33, Issue 12, 2012, Pages 1000-1003
|
[Clinical efficacy of immunotherapy of dendritic cell and cytokine-induced killer cell combined with chemotherapy for treatment of multiple myeloma].
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ANTINEOPLASTIC AGENT;
ADOPTIVE IMMUNOTHERAPY;
ADULT;
AGED;
ARTICLE;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
CYTOKINE INDUCED KILLER CELL;
DENDRITIC CELL;
FEMALE;
HUMAN;
IMMUNOLOGY;
MALE;
MIDDLE AGED;
MULTIMODALITY CANCER THERAPY;
MULTIPLE MYELOMA;
RANDOMIZED CONTROLLED TRIAL;
TREATMENT OUTCOME;
ADULT;
AGED;
ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS;
COMBINED MODALITY THERAPY;
CYTOKINE-INDUCED KILLER CELLS;
DENDRITIC CELLS;
FEMALE;
HUMANS;
IMMUNOTHERAPY, ADOPTIVE;
MALE;
MIDDLE AGED;
MULTIPLE MYELOMA;
TREATMENT OUTCOME;
|
EID: 84887202477
PISSN: 02532727
EISSN: None
Source Type: None
DOI: None Document Type: Article |
Times cited : (9)
|
References (0)
|